Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente CLINICAL & TRANSLATIONAL ONCOLOGY

Tipo Año Título Fuente
Artículo2024Interdisciplinary Spanish consensus on a watch-and-wait approach for rectal cancerCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2024Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECPCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2024Palliative care for children with central nervous system tumors: results of a Spanish multicenter studyCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2024The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual SymposiumCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2024The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapyCLINICAL & TRANSLATIONAL ONCOLOGY
Revisión2023A genetic profiling guideline to support diagnosis and clinical management of lymphomasCLINICAL & TRANSLATIONAL ONCOLOGY
Revisión2023Adverse events of antibody–drug conjugates on the ocular surface in cancer therapyCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2023Correction to. New update to the guidelines on testing predictive biomarkers in non‑small‑cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical OncologyCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2023Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancerCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2023Haematological and renal toxicity of radiation therapy in neuroblastoma paediatric patientsCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2023New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical OncologyCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2022Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)CLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2022Multidisciplinary consensus on the criteria for fertility preservation in cancer patientsCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2022SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021)CLINICAL & TRANSLATIONAL ONCOLOGY
Otros2021Digital twins in healthcare: an application in radiation oncologyCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2021GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcomaCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2021Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumoursCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2021SEOM clinical guideline for the management of cutaneous melanoma (2020)CLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2021The paediatric cancer clinical research landscape in Spain: a 13-year multicentre experience of the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)CLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2020Analysis of mismatch repair (MMR) proteins expression in a series of malignant pleural mesothelioma (MPM) patientsCLINICAL & TRANSLATIONAL ONCOLOGY
Corrección2020Correction to: Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical OncologyCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2020Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practiceCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2020Impact of pre-radiation therapy quality of life in lung cancer survival: a prospective, intention-to-treat, multicenter studyCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2020Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical OncologyCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2020Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIMCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2020Multidisciplinary management of liver metastases in patients with colorectal cancer:: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIMCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2020SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)CLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2020Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP)CLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2020Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma:: a Delphi consensusCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2020Updated guidelines for predictive biomarker testing in advanced non‑small‑cell lung cancer:: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical OncologyCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2019Active surveillance as a successful management strategy for patients with clinical stage I germ cell testicular cancerCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2019Cardiovascular disease and survival in non-small cell lung cancer: a multicenter prospective assessmentCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2019ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in SpainCLINICAL & TRANSLATIONAL ONCOLOGY
Revisión2019New horizons in breast cancer: the promise of immunotherapyCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2019Outcome and toxicity of intensity-modulated radiotherapy with simultaneous integrated boost in patients with pharyngo-laryngeal cancerCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2019SEOM clinical guidelines in advanced and recurrent breast cancer (2018)CLINICAL & TRANSLATIONAL ONCOLOGY
Revisión20182018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primaryCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2018Analysis of blood markers for early breast cancer diagnosisCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2018Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 yearsCLINICAL & TRANSLATIONAL ONCOLOGY
Corrección2018Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice (vol 20, pg 862, 2018)CLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2018Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practiceCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2018Integral nutritional approach to the care of cancer patients: results from a Delphi panelCLINICAL & TRANSLATIONAL ONCOLOGY
Editorial2018New wind for the Spanish Federation of Scientific Oncological Societies (FESEO)CLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2018Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFHCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2018Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFHCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2018SEOM clinical guideline for the management of malignant melanoma (2017)CLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2018SEOM clinical guidelines in gestational trophoblastic disease (2017)CLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2018The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolismCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2017A consensus statement on the gender perspective in lung cancerCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2017Clinical and pathologic features of patients with non-epithelial ovarian cancer: retrospective analysis of a single institution 15-year experienceCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2017Cost minimization analysis of treatment with intravenous or subcutaneous trastuzumab in patients with HER2-positive breast cancer in SpainCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2017Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?CLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2017Defining the optimal sequence for the systemic treatment of metastatic breast cancerCLINICAL & TRANSLATIONAL ONCOLOGY
Revisión2017Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish RegionsCLINICAL & TRANSLATIONAL ONCOLOGY
Corrección2017Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions (vol 19, pg 341, 2017)CLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2017FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidenceCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2017Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapyCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2017Outcome and toxicity of intensity modulated radiotherapy with simultaneous integrated boost in locally advanced non-small cell lung cancer patientsCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2016Clinical use of ipilimumab for metastatic melanoma in Spain: towards a more consistent approachCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2016Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi studyCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2016Safety of vemurafenib in patients with BRAF (V600) mutated metastatic melanoma: the Spanish experienceCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2016Trends in lung cancer incidence by histologic subtype in the south of Spain, 1985-2012: a population-based studyCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2015Adjuvant regimens with trastuzumab administered for small HER2-positive breast cancer in routine clinical practiceCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2015Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical OncologyCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2015Effectiveness and toxicity of helical tomotherapy for patients with locally recurrent nasopharyngeal carcinomaCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2015Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancerCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2015Genetic modification of hypoxia signaling in animal models and its effect on cancerCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2015SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphomaCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2015SEOM clinical guidelines for the treatment of Hodgkin's lymphomaCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2015SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015CLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2015SEOM clinical guidelines in metastatic breast cancer 2015CLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2014Clinical guideline SEOM: cancer of unknown primary siteCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2014Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologistsCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2013Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkersCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2013Proteomic biomarkers in lung cancerCLINICAL & TRANSLATIONAL ONCOLOGY
Editorial2012A new multidisciplinary Spanish Working Group on Cancer Biomarkers: presentation and aimsCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2012A prospective biological study in relation to a family with Li-Fraumeni syndromeCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2012Biological markers of cisplatin resistance in advanced testicular germ cell tumoursCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2012Castration-resistant metastatic prostate cancer: current status and treatment possibilitiesCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2012Functions and workload of medical oncologists in SpainCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2012Guidelines for biomarker testing in advanced non-small-cell lung cancer.: A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)CLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2012Pilot study on workload estimate in breast cancer, lung cancer and colorectal cancer in a Medical Oncology Service at Valme hospitalCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2012Prognostic factors for overall survival in paediatric patients with Ewing sarcoma of bone treated according to multidisciplinary protocolCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2011Fine-needle aspiration cytopathology in the diagnosis of Wilms tumorCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2011Pseudomyxoma peritonei treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy:: results from a single centreCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2011The therapeutic potential of TRAIL receptor signalling in cancer cellsCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2010Expression of EGFR, HER-2/neu and KIT in germ cell tumoursCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2010Primary intracranial malignant peripheral nerve sheath tumour responding to chemotherapyCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2009Role of transforming growth factor β in cancer microenvironment CLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2009The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancerCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2008A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancerCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2008Cancer stem cells and brain tumorsCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2007Molecular pathology in sarcomasCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2007Molecular pathology in sarcomasCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2007Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposalsCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2007Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposalsCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2005Embryonic tumours of the central nervous systemCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2005Linitis plástica primaria rectalCLINICAL & TRANSLATIONAL ONCOLOGY
Editorial2004The need for a State Pact for Science in SpainCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2003PA2.26 antigen (T1a/podoplanin): A small mucin-like transmembrane glycoprotein associated with cell migration and cancerCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2001Bacteremia caused by Leuconostoc spp. in a neutropenic patient with ovarian adenocarcinomaCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2001Pneumocystic carinii pneumonia and solid organ cancerCLINICAL & TRANSLATIONAL ONCOLOGY
Artículo2001Preoperative radiotherapy versus surgery as therapy in rectal carcinomaCLINICAL & TRANSLATIONAL ONCOLOGY
Revisión2000Quimioterapia preoperatoria en el tumor de WilmsCLINICAL & TRANSLATIONAL ONCOLOGY